Low UBE4B expression increases sensitivity of chemoresistant neuroblastoma cells to EGFR and STAT5 inhibition. [electronic resource]
- Cancer biology & therapy 2019
- 1416-1429 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1555-8576
10.1080/15384047.2019.1647049 doi
Apoptosis--drug effects Biomarkers Cell Line, Tumor Cell Movement Cell Proliferation--drug effects Cetuximab--pharmacology Drug Resistance, Neoplasm--genetics ErbB Receptors--antagonists & inhibitors Humans Neuroblastoma--drug therapy Protein Array Analysis Protein Kinase Inhibitors--pharmacology STAT5 Transcription Factor--antagonists & inhibitors Tumor Suppressor Proteins--antagonists & inhibitors Ubiquitin-Protein Ligases--genetics